18 completed, 4 unknown, 3 not yet recruiting, 3 recruiting. 30 Phase 2, 4 Phase 3, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 30 | Completed 18, Unknown 4, Not yet recruiting 3, Recruiting 3, Terminated 1, Withdrawn 1 |
| Phase 3 | 4 | Completed 2, Not yet recruiting 1, Recruiting 1 |
| Phase 1 | 1 | Completed 1 |
Follow Methylene Blue: new trials by email Literature Review of Methylene Blue trials Research Report on Methylene Blue
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy of Methylene Blue Photodynamic Therapy for Treatment of Deep Tissue Abscesses Methylene Blue, Lipid Emulsion, Insertion of optical fiber - Abscess | Phase 2 | Not yet recruiting | University of Rochester | 150 | 2027-07-15 | 2026-11-17 |
| A Phase 2 Study of Methylene Blue Photodynamic Therapy for Treatment of Breast Abscesses Standard of care breast abscess drainage, Methylene Blue, Lipid Emulsion - Breast Abscess | Phase 2 | Not yet recruiting | University of Rochester | 50 | 2027-07-01 | 2026-08-19 |
| Early Methylene Blue in the Microhemodynamics of Septic Patients Methylene blue infusion - Septic Shock, Hypoperfusion | Phase 2 / Phase 3 | Recruiting | Centro de Estudos e Pesquisa em Emergencias Medicas e Terapia Intensiva | 50 | 2026-01-09 | 2026-03-27 |
| Local Methylene Blue Injection for Prevention of Anastomotic Leakage and Permanent Stoma After Low Anterior Resection for Rectal Cancer methylene blue injection - Rectal Cancers | Phase 2 | Recruiting | Peking University Cancer Hospital & Institute | 26 | 2025-11-25 | 2026-09-22 |
| Methylene Blue Treatment of Chronic Hepatitis B Virus Infection Methylene Blue - Chronic HBV Infection | Phase 2 | Recruiting | Fondazione Epatocentro Ticino | 10 | 2025-09-01 | 2026-08-21 |
| Intravenous Methylene Blue for Treating Refractory Neonatal Septic Shock Methylene Blue, Placebo - Neonatal Sepsis, Shock, Septic | Phase 2 / Phase 3 | Not yet recruiting | Post Graduate Institute of Medical Education and Research, Chandigarh | 130 | 2024-03-15 | 2024-03-12 |
| Low Dose Versus High Dose Methylene Blue in Septic Patients Normal saline, Methylene Blue low dose, Methylene Blue high dose - Septic Shock | Phase 2 / Phase 3 | Completed | National Cancer Institute, Egypt | 90 | 2023-08-01 | 2024-07-05 |
| Nasal Photodisinfection in All Patients Presenting for Surgery for a Wide Range of Surgical Procedures methylene blue 0.01%/chlorhexidine gluconate 0.25% + light activation - Surgical Site Infections, Nosocomial Infection | Phase 2 | Completed | Ondine Biomedical Inc. | 322 | 2022-02-04 | 2022-08-22 |
| Methylene Blue for the Prevention of Hypotension During Hemodialysis Methylene Blue, Control - Acute Kidney Injury, Shock | Phase 2 | Completed | Federal University of São Paulo | 261 | 2021-10-21 | 2026-04-17 |
| COVID-19 Methylene Blue Antiviral Treatment Methylene Blue, Saline nasal spray - Covid19 | Phase 2 | Completed | Irkutsk Scientific Center of the Siberian Branch of the Russian Academy of Sciences | 24 | 2021-08-06 | 2022-02-09 |
| Methylene Blue-Enhanced Ultrafiltration Improves Outcomes After Cardiopulmonary Bypass Methylene Blue, Conventional ultrafiltration, Zero-balance ultrafiltration - Cardiopulmonary Bypass Surgery, Aortic Valve Surgery | Phase 2 | Completed | University of Sao Paulo | 124 | 2021-04-12 | 2025-10-08 |
| Hidradenitis Suppurativa Wound Care methylene blue, gentian violet, and ovine forestomach wound dressings - Hidradenitis Suppurativa (HS) | Phase 2 | Completed | Wake Forest University Health Sciences | 5 | 2021-02-04 | 2025-10-22 |
| Methylene Blue Treatment of COVID-19 Methylene Blue, Control Test - SARS-CoV2 | Phase 2 | Completed | Fondazione Epatocentro Ticino | 29 | 2020-11-05 | 2025-08-17 |
| Exchange Transfusion Versus Plasma From Convalescent Patients With Methylene Blue in Patients With COVID-19 exchange blood transfusion from normal donor, plasma from convalescent patients with COVID-19, Methylene Blue 5 MG/ML - COVID-19 | Phase 2 | Unknown | Ain Shams University | 15 | 2020-05-20 | 2020-07-09 |
| Methylene Blue as a Third-line Vasopressor in Septic Shock Methylene Blue, Phenylephrine - Septic Shock | Phase 2 | Unknown | Carilion Clinic | 250 | 2019-12-01 | 2022-07-26 |
| Hemodynamic Effects of Methylene Blue vs Hydroxocobalamin in Patients at Risk of Vasoplegia During Cardiac Surgery Hydroxocobalamin, Methylene Blue, Normal saline - Vasoplegia, Hypotension | Phase 2 | Withdrawn | Dartmouth-Hitchcock Medical Center | 2019-11-01 | 2020-03-02 | |
| MOM's PAIN (Methylene Blue for Oral Mucositis' PAIN) Best Practice, Methylene Blue - Malignant Neoplasm, Oral Pain | Phase 2 | Completed | M.D. Anderson Cancer Center | 69 | 2019-02-28 | 2023-04-25 |
| Methylene Blue Versus Vasopressin Analogue for Treatment of Septic Shock in Preterm Neonate Methylene Blue - Neonatal Sepsis, Refractory Shock | Phase 2 | Unknown | Ain Shams University | 36 | 2019-02-19 | 2019-10-01 |
| Methylene Blue in Early Septic Shock 0.9% sodium chloride, Methylene Blue - Septic Shock | Phase 2 / Phase 3 | Completed | Hospital Civil de Guadalajara | 91 | 2017-03-17 | 2022-11-04 |
| Methylene Blue Against Falciparum Malaria in Burkina Faso Methylene Blue, Primaquine - Malaria, Falciparum | Phase 2 | Completed | Heidelberg University | 100 | 2016-10-01 | 2020-03-25 |
Showing 20 of 30. Sign in to see all of them.
Shock, Septic (6) · Breast Neoplasms (2) · COVID-19 (2) · Malaria (2) · Neonatal Sepsis (2) · Shock (2) · Abscess (1) · Acute Kidney Injury (1) · Alzheimer Disease (1) · Cognitive Dysfunction (1) · Coronary Artery Disease (1) · Cross Infection (1) · Disease (1) · Elimination Disorders (1) · Heart Valve Diseases (1)
Heidelberg University (3) · Ain Shams University (2) · Fondazione Epatocentro Ticino (2) · University of Rochester (2) · Carilion Clinic (1) · Centro de Estudos e Pesquisa em Emergencias Medicas e Terapia Intensiva (1) · Dartmouth-Hitchcock Medical Center (1) · Federal University of São Paulo (1) · Hospital Civil de Guadalajara (1) · Irkutsk Scientific Center of the Siberian Branch of the Russian Academy of Sciences (1) · Louisiana State University Health Sciences Center in New Orleans (1) · M.D. Anderson Cancer Center (1) · National Cancer Institute, Egypt (1) · Ondine Biomedical Inc. (1) · Peking University Cancer Hospital & Institute (1)
United States (11) · Brazil (3) · Burkina Faso (3) · Egypt (3) · Switzerland (2) · United Kingdom (2) · China (1) · India (1) · Iran (1) · Mali (1) · Mexico (1) · Russia (1)
Alassane Dicko, MD (1) · Ashwani K Sharma, MD (1) · Ayman I Tharwat, MD (1) · Carla Pontes, MD (1) · Carlos Roldan (1) · Dennis Holmes (1) · Ehab H Shaker, MD (1) · Eugene A Woltering, MD (1) · Flavia R Machado, MD, PhD (1) · Frank Biscardi (1) · Laurie Christensen, BS (1) · Lori A Zoellner, PhD (1) · Miguel Ibarra-Estrada, MD (1) · Mohamed M Moussa, MD (1) · Olaf Mueller, MD, MPH (1)
PMID 36915146, PMID 11588440, PMID 12500513, PMID 12519925, PMID 14759425, PMID 16134766, PMID 17698886, PMID 18286187, PMID 18477932, PMID 19415120, PMID 21246318, PMID 25267980, PMID 26683506, PMID 27673307, PMID 28686823, PMID 28723883, PMID 29151412, PMID 29422384, PMID 29508706, PMID 29936590, PMID 30231909, PMID 31600221, PMID 32270211, PMID 32453920, PMID 32520577, PMID 34719443, PMID 36237547, PMID 36324139, PMID 36505110, PMID 36705345, PMID 39780053, PMID 8648456, PMID 9250657
R34MH087375 (1)